Page last updated: 2024-11-01

nomifensine and Benign Hypothalamic Neoplasms

nomifensine has been researched along with Benign Hypothalamic Neoplasms in 3 studies

Nomifensine: An isoquinoline derivative that prevents dopamine reuptake into synaptosomes. The maleate was formerly used in the treatment of depression. It was withdrawn worldwide in 1986 due to the risk of acute hemolytic anemia with intravascular hemolysis resulting from its use. In some cases, renal failure also developed. (From Martindale, The Extra Pharmacopoeia, 30th ed, p266)
nomifensine : An N-methylated tetrahydroisoquinoline carrying phenyl and amino substituents at positions C-4 and C-8, respectively.

Research Excerpts

ExcerptRelevanceReference
"The normality of the GH-ACTH-secreting pituitary tumors and hypothalamic tumor responses to TRH is one more factor in differentiating these from prolactinomas."1.27Evidence of abnormal dopaminergic control of prolactin in patients with hypothalamic and pituitary tumors. ( Almoguera, I; Cabranes, JA; Charro, AL; del Olmo, J; Pablos, I; Prensa, A, 1986)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kamoi, K1
Tchuchida, I1
Sato, H1
Tanaka, R1
Ishiguro, T1
Kaneko, K1
Iwasaki, Y1
Shibata, A1
Cabranes, JA1
Almoguera, I1
del Olmo, J1
Prensa, A1
Pablos, I1
Charro, AL1
Barbarino, A1
De Marinis, L1
Mancini, A1
Menini, E1
D'Amico, C1
Passeri, M1
Sambo, P1
Anile, C1
Maira, G1

Other Studies

3 other studies available for nomifensine and Benign Hypothalamic Neoplasms

ArticleYear
Comparison of the responses in the nomifensine test with hyperprolactinemia due to prolactin-secreting pituitary tumors and nonprolactin-secreting hypothalamic tumors.
    The Journal of clinical endocrinology and metabolism, 1981, Volume: 53, Issue:6

    Topics: Adenoma; Adult; Female; Humans; Hypothalamic Neoplasms; Isoquinolines; Male; Middle Aged; Nomifensin

1981
Evidence of abnormal dopaminergic control of prolactin in patients with hypothalamic and pituitary tumors.
    Journal of medicine, 1986, Volume: 17, Issue:1

    Topics: Adrenocorticotropic Hormone; Domperidone; Female; Growth Hormone; Humans; Hypothalamic Neoplasms; Ma

1986
Prolactin dynamics in patients with non-secretin tumours of the hypothalamic-pituitary region.
    Acta endocrinologica, 1985, Volume: 110, Issue:1

    Topics: Adenoma; Adenoma, Chromophobe; Adolescent; Adult; Craniopharyngioma; Female; Follicle Stimulating Ho

1985